United States: TMT Insights: What Is On The Horizon For Export Controls On "Emerging Technologies"? Industry Comments May Hold A Clue

Following last year's enactment of the Foreign Investment Risk Review Modernization Act ("FIRRMA"), the U.S. Department of Commerce ("DOC") is currently reviewing the public comments it has received on how to define and identify a new category of "critical technologies" created by FIRRMA: "emerging technologies." In November 2018, the DOC published an Advance Notice of Proposed Rulemaking ("ANPRM") to assist it in developing criteria for identifying "emerging technologies" that are essential to U.S. national security. Once identified, these will be subject to U.S. export controls and also will be considered "critical technologies" for purposes of review by the Committee on Foreign Investment in the United States ("CFIUS"), including under the CFIUS Pilot Program enacted last November.

The ANPRM is the first major step taken by the DOC as part of an inter-agency process provided by the Export Control Reform Act of 2018 ("ECRA") to identify which "emerging" and "foundational" technologies are essential to U.S. national security and should be covered by U.S. export controls. The ANPRM invited public comment on 14 broad categories of technologies – including artificial intelligence ("AI"), machine learning ("ML"), nanotechnology, additive manufacturing, and biotechnology – each of which included several subcategories.

Key Takeaways

  • The DOC's ANPRM signals an important step in the expansion of CFIUS's purview – including under the Pilot Program – to review foreign investments in a new category of "emerging technologies" created by FIRRMA.
  • Although the DOC has yet to issue final rules to identify emerging technologies – or even propose rules – the ANPRM signals DOC's desire to take an expansive look at many important U.S. technologies, including AI, ML, additive manufacturing, robotics, and quantum computing.
  • The DOC's processes will culminate in a final list of Export Control Classification Numbers for any covered "emerging technologies."
  • Because any technology that is identified by the DOC as "emerging" will also be considered a "critical technology" by CFIUS, companies involved in any of the technologies so identified should consult with counsel about whether voluntary or mandatory CFIUS filings will be required in the event of foreign investments.

Export Controls for "Emerging Technologies": The Public Weighs In

In response to the ANPRM, nearly 250 foreign and domestic corporations, industry associations, advocacy groups, and educational institutions submitted comments. A consensus of many of the principal commenting parties urged DOC to reject a broad brush approach to defining "emerging technologies" because that could negatively affect U.S. technological innovation and global competitiveness. Moreover, they noted, most of the ANPRM's "representative" technologies – such as AI, ML, biotechnology and additive manufacturing – have already been in widespread, commercial use for years, so they are hardly "emerging" and should not be subject to export controls. As one commentator noted, "[t]here is no need to control a technology that is already widely available in the global marketplace." Other commentators have suggested that technologies should not be considered "emerging" too early in their development lifecycles (i.e., before they have a viable proof of concept).

Commenters generally urged that:

  • "Emerging" technologies be limited to early-stage, developmental technologies – not those that are widely available or are in broad production use;
  • Technologies should be subject to controls only if they are both "essential" to national security and not already covered by existing export control regimes;
  • The DOC should specify controlled technologies with precision and only if the military needs or national security applications that give rise to the need for concern are identified;
  • Any export controls should be based on particular applications, end uses or end users, not on the technologies as such;
  • The DOC should rely on industry expertise with respect to identifying particular technologies that are candidates for control;
  • Government controls should be implemented through multilateral regimes, with exceptions for allies; and
  • Technologies that the DOC concludes might warrant controls should be subject to further public comment.

Many commentators also weighed in with specific comments on the "representative" categories or subcategories of technologies identified in the ANPRM, such as:

  • AI and ML. AI and ML are mature technologies with applications across multiple industries. Neural networks, deep learning, and computer vision, and natural language processing have all progressed beyond the stage of fundamental research to widescale commercial deployment, and the U.S. is only one of several leading countries in this field. According to the commentators, placing export controls on AI and ML would not protect U.S. national security interests; instead, it would create barriers to U.S. technological leadership, particularly in that globally important and fast-paced industry.
  • Biotechnology. Commentators urged DOC to recognize that biotechnology is a mature, global field. The specific subcategories identified by the ANPRM, such as synthetic biology and genetic engineering, have been in widespread use for decades in a competitive global market; for that reason, these technologies not well suited to export controls.
  • Quantum Information and Sensing Technology. Although some commentators described quantum computing as in its infancy, quantum encryption is already used globally by financial institutions. As quantum computing continues to be a focus of U.S. university research programs, commentators cautioned that export controls could place the U.S. at a competitive disadvantage by preventing U.S. entities from participating in international research collaborations.
  • Additive Manufacturing (e.g., 3D Printing). Although recent advances have enabled additive manufacturing techniques to be used for new materials (such as metals, ceramics, and conductors), commercial applications are used widely in the automotive, medical, and aerospace industries. Additionally, Germany, Sweden, Israel, China, South Korea, and Russia are global leaders in additive manufacturing technologies, and foreign companies have traditionally been attractive targets for acquisition by U.S. companies. Thus, while additive manufacturing may be used in the defense industry, commentators urged the DOC to limit export controls to specific tools, materials, or processes (e.g., explosives, warhead materials).
  • Microprocessors. Although microprocessor technology is essential to defense objectives, it is already controlled under the current U.S. export regime. Accordingly, commentators suggested that additional controls on additional microprocessor tools or materials may be unnecessary.

Next Steps and Opportunities for Further Comment

The DOC is expected to identify "emerging technologies" in a follow-on rulemaking, which will likely provide companies with another opportunity to submit comments. Once the DOC identifies the emerging technologies to be controlled, it will issue new Export Control Classification Numbers governing the technologies' export, re-export or transfer.

Companies likely to be affected by the new designations should consider submitting comments in response to the subsequent rule-making processes. Alternatively, they could reach out to the DOC about the possibility of submitting comments on a confidential basis.

Separately, the DOC is also expected to issue an Advanced Notice of Proposed Rulemaking for "foundational technologies." At this point, the DOC has not provided any guidance on which technologies this will cover nor a timeline for the rule-making process.

As we have previously discussed, any technology identified as emerging or foundational by DOC will be considered a "critical technology" for the purposes of determining whether CFIUS review is warranted (or required, in the event of the Pilot Program) in the event of a foreign investment. Accordingly, companies that develop or use such technologies, are potential targets for foreign investment or are foreign investors focused on these sectors will want to pay attention to these developments and consult with counsel as to whether a CFIUS filing should (or must) be made.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions